NCT02122874View on ClinicalTrials.gov

Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Diabetes Mellitus Type 2 in ObeseType 2 Diabetes Mellitus With Features of Insulin Resistance
Interventions
DEVICE

Percutaneous Neurostimulation (PENS) of dermatome T7

The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet

OTHER

1200 Kcal diet

Trial Locations (1)

03203

General Hospital Elche, Elche

All Listed Sponsors
lead

Hospital General Universitario Elche

OTHER

NCT02122874 - Percutaneous Electric Neurostimulation of Dermatome T7 Improves Glycemic Profile in Obese and Typo 2 Diabetic Patients | Biotech Hunter | Biotech Hunter